Clin2
NCT06590298Possibly a fitNot yet recruiting

Aripiprazole for weight and metabolism in women on antipsychotics

PsychosisMetabolic SyndromeWeight Gain

Part of Hormones & metabolism, Mental health clinical trials.

This study tests whether adding aripiprazole to your current antipsychotic medication can help with weight gain and metabolic side effects. It is for women aged 18 to 65 who have schizophrenia or schizoaffective disorder and are currently taking olanzapine, clozapine, or risperidone.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
600 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are a woman between 18 and 65 years old.
  • You have been diagnosed with schizophrenia or schizoaffective disorder.
  • You have been taking one of these antipsychotics for at least a month: olanzapine, clozapine, or risperidone.
  • You are not pregnant or breastfeeding.
  • You do not have any serious medical conditions that affect weight or metabolism (like uncontrolled thyroid problems).
  • You have no history of bad reaction to aripiprazole.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06729671Recruiting
Probiotics for antipsychotic-related metabolic issues

This trial tests if a probiotic supplement can help reduce metabolic side effects (like weight gain or high blood sugar) caused by antipsychotic medications. It is for people with psychosis who are on stable treatment.

Cork
NCT07386483Not yet recruiting
Strength training timing to prevent antipsychotic weight gain

This trial tests if doing resistance training at a specific time of day can help prevent the metabolic side effects (like weight gain and blood sugar changes) caused by antipsychotic medications in people recently diagnosed with psychosis.

Dublin
NCT06251635Recruiting
Antipsychotics and brain insulin in women

This study looks at how a common antipsychotic medication (olanzapine) affects how the brain uses insulin in young women. It aims to understand weight gain and metabolic changes linked to these drugs.

Toronto, Ontario
NCT05303064Recruiting· Phase 3
Study of weight gain medicine for teens with certain mood or psychosis

This Phase 3 study tests a treatment aimed at reducing unhealthy weight gain in teens with schizophrenia or bipolar I disorder, using changes in BMI (a height-and-weight measure). It may help families who are concerned about weight changes that can happen with some psychiatric medicines.

Dothan, Alabama
NCT06649214Not yet recruiting· Phase 3
Study of a new schizophrenia medication tablets

This trial tests a new combination tablet (olanzapine-samidorphan) for adults with schizophrenia. It aims to see if it helps control symptoms while potentially reducing weight gain, which can be a side effect of some schizophrenia medicines.

NCT07606014Recruiting· Phase 2/Phase 3
Probiotics to Support Mental Health Treatment

This study tests whether taking special probiotics (beneficial bacteria) can help prevent weight gain and metabolic changes when starting antipsychotic medications for psychosis. You'd take probiotics daily while beginning or recently starting one of four common antipsychotic drugs.

Leeuwarden, Provincie Friesland

Hear when a new Psychosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.